General Information of the Compound
| Compound ID |
CP0451435
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(1,3-benzothiazol-5-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H18N4OS
|
||||||||||||||||||
| Molecular Weight |
314.414
|
||||||||||||||||||
| Canonical SMILES |
C1N=C(Nc2ccc3scnc3c2)OC11CN2CCC1CC2
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H18N4OS/c1-2-14-13(18-10-22-14)7-12(1)19-15-17-8-16(21-15)9-20-5-3-11(16)4-6-20/h1-2,7,10-11H,3-6,8-9H2,(H,17,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GIXVQDNIPFHYIN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02227, 5-hydroxytryptamine receptor 3A
Protein ID: PT02118, Neuronal acetylcholine receptor subunit alpha-7